Financial Information

Annual Report

2022-2023 Annual Report 

2021-2022 Annual Report

2020-2021 Annual Report

2019-2020 Annual Report

2018-2019 Annual Report

2017-2018 Annual Report

2016-2017 Annual Report

 

Financial Statement

Annual General Meeting

Sign the petition and MAKE A DIFFERENCE!

This Lupus Ontario petition is advocating to have the Ontario government approve all biologics approved by the Federal Health Agency (CADTH) added to the Ontario Drug Formulary under the Limited Use code rather that the Exceptional Access Program. The Limited Use code eliminates the administrative burden for rheumatologists and provides faster access for lupus patients. Please print and gather signatures and send it to our address: 285 Taunton Road East, Suite 4438, Oshawa, ON  L1G 3V2 Canada